Literature DB >> 16421494

Primary cytomegalovirus disease after five years of antiviral prophylaxis.

Supha Kijpittayarit, Paul Deziel, Albert J Eid, Raymund R Razonable.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16421494     DOI： 10.1097/01.tp.0000190424.30178.43

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  1 in total

1.  Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients.

Authors:  Sameh Adel Fayek; Wana Mantipisitkul; Flavia Rasetto; Raghava Munivenkatappa; Rolf N Barth; Benjamin Philosophe
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.